Immatics NV

Immatics N.V. is a pioneer in the field of cancer therapeutics, specialising in T-cell therapy. The company operates globally, offering transformative and integrative therapeutic solutions for various forms of cancer. Within the biotechnology sector, Immatics is a major player. The company is involved in discovering and developing T-cell-engaging cancer immunotherapies and other relevant therapeutic services. Despite being a distinct entity, collaborations with large pharmaceutical giants like Genmab have made the company noteworthy within the industry. Follow the latest movements in the biotech sector by tracking IMTX's share price on your eToro watchlist.